New insights into mechanisms of allograft rejection

American Journal of the Medical Sciences

Volumn 313, Issue 5, 1997, Pages 257-263

  Pattison, James M ^a   Krensky, Alan M ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Allograft rejection; Human leukocyte antigen (HLA); Immunology; T lymphocytes; Transplantation

Indexed keywords

ALLOANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; CYCLOSPORIN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; T LYMPHOCYTE RECEPTOR; TACROLIMUS;

ALLOGRAFT; ANTIGEN RECOGNITION; ARTICLE; CELL INTERACTION; CYTOTOXICITY; GRAFT REJECTION; IMMUNOTHERAPY; NONHUMAN; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0030908270     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9629(15)40113-2     Document Type: Article

References (30)

1. Suthanthiran M, Strom TB. Renal Transplantation. N Engl J Med. 1994;331:365-76.
2. Krensky AM, Weiss A, Crabtree G, Davis MM, Parham P. T-Lymphocyte-Antigen Interactions in Transplant Rejection, N Engl J Med. 1990;322:510-7.
3. Hansen TH, Carreno BM, Sachs DH. The Major Histocompatibility Complex. In: Paul WE, ed. Fundamental Immunology. New York: Raven Press; 1993;577-628.
4. Germain RN. MHC-dependent antigen processing and peptide presentation. Providing ligands for T cell activation. Cell. 1994;76:288-99.
5. Zinkernagel RM and Doherty PC. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature. 1974;248:701-2.
6. Bjorkman PJ, Saper MA, Samraoul B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 1987;329:506-12.
7. Sanderson F, Kleijmeer N, Kelly A, Verwoerd D, Tulp A, Neefjes JJ, et al. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science. 1994;266:1566-9.
8. Scott DM, Ehrmann IE, Ellis PS, Bishop CE, Agulnik AI, Simpson E, et al. Identification of a mouse male-specific transplantation antigen. H-Y. Nature. 1995;376:695-8.
9. Lechler R, Batchelor J. Restoration of immunogenicity to passenger cell depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med. 1982;155:31-41.
10. Fangmann J, Dalchau R, Fabre JW. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med. 1992;175:1521-9.
11. Pober JS, Orosz G, Rose ML, Savage COS. Can graft endothelial cells initiate a host anti-graft immune response? J Exp Med. 1996;61:343-9.
12. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell. 1994;76:263-74.
13. Flanagan WM, Corthesy B, Bram RJ, Crabtree GR. Nuclear association of a T-cell transcription factor blocked by FK506 and cyclosporin A. Nature. 1991;352:803-7.
14. Linsley PS, Ledbetter JA. The role of CD28 receptor during T cell responses to antigen. Ann Rev Immunol. 1993;11:191-212.
15. Boussiotis VA, Gribben JG, Freeman GJ, Nadler LM. Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance. Curr Opin Immunol. 1994;6:797 -807.
16. Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, et al. Long term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science. 1992;257:789-92.
17. Boise LH, Noel PJ and Thompson CB. CD28 and apoptosis. Curr Opin Immunol. 1995;7:620-5.
18. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 1995;270:985-8.
19. Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, Wakeham A, et al. Differential T-cell costimulatory requirements in CD28-deficient mice. Science. 1993;261:609-12.
20. Nickerson P, Steurer W, Steiger J, Zheng X, Steele AW, Strom TB. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol. 1994;6:757-64.
21. Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, et al. Interleukin-2 receptor γ chain: A Functional Component of the Interleukin-4 Receptor. Science. 1993;262:1880-3.
22. Bromberg JS. IL-10 immunosuppression in transplantation. Curr Opin Immunol. 1995;7:639-43.
23. Gorczynski RM, Wojcik D. A role for nonspecific (cyclosporin) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL- 10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion. J Immunol. 1994;152:2011-9.
24. Zheng XX, Steele AW, Nickerson PW, Stevrer W, Steiger J, Strom TB. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J Immunol. 1995;154:5590-5600.
25. Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen KJ, et at. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 1994a;369:31-7.
26. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell. 1994;76:977-87.
27. Lipman ML, Stevens AC, Strom TB. Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J Immunol. 1994;152:5120-7.
28. Larsen CF, Alexander DZ, Hendrix R, Elwood ET, Ritchie SC, Aruffo A, et al. Fas-mediated cytotoxicity. Transplantation. 1996;60:221-4.
29. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-14.
30. Briscoe DM, Yeung A, Schoen EL, Allred EN, Staurakis G, Gant P, et al. Predictive value of inducible endothelial cell adhesion molecule expression for acute rejection of human cardiac allografts. Transplantation. 1995;59:204-11.